Michael J Fedida Net Worth

The estimated Net Worth of Michael J Fedida is at least $1.54 Milion dollars as of 12 March 2013. Michael Fedida owns over 8,000 units of Enact Inc stock worth over $825,731 and over the last 12 years Michael sold ACT stock worth over $712,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Fedida ACT stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Enact Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Michael sold 8,000 units of ACT stock worth $712,000 on 12 March 2013.

The largest trade Michael's ever made was selling 8,000 units of Enact Inc stock on 12 March 2013 worth over $712,000. On average, Michael trades about 2,667 units every 0 days since 2013. As of 12 March 2013 Michael still owns at least 23,505 units of Enact Inc stock.

You can see the complete history of Michael Fedida stock trades at the bottom of the page.

What's Michael Fedida's mailing address?

Michael's mailing address filed with the SEC is 400 Interpace Pkwy, Parsippany, NJ 07054, USA.

Insiders trading at Enact Inc

Over the last 12 years, insiders at Enact Inc have traded over $742,398,702 worth of Enact Inc stock and bought 189,956 units worth $3,738,670 . The most active insiders traders include Holdings, Inc. Genworth, Daniel J Iv Sheehan oraz Michael A Bless. On average, Enact Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,061,714. The most recent stock trade was executed by Holdings, Inc. Genworth on 30 August 2024, trading 697,093 units of ACT stock currently worth $23,401,412.

What does Enact Inc do?

Enact Holdings, Inc. operates as a holding company. Through its subsidiaries, Enact provides mortgage insurance services to mortgage lenders and investors.

Complete history of Michael Fedida stock trades at Enact Inc

Enact Inc executives and stock owners

Enact Inc executives and other stock owners filed with the SEC include:

• Rohit Gupta,
  Pres, CEO & Director
• Hardin Dean Mitchell,
  EVP, CFO & Treasurer
• Evan Scott Stolove,
  Exec. VP, Gen. Counsel & Sec.
• Piotr Bielinski,
  Chairman of the Management Board
• Slawomir Harazin,
  Vice Chairman of the Management Board
• Iwona Bocianowska,
  Chairwoman of the Supervisory Board
• Krzysztof Kaczmarczyk,
  Member of the Supervisory Board
• Piotr Chajderowski,
  Independent Member of the Supervisory Board
• Marek Jakubowski,
  Secretary of the Supervisory Board
• Adam Switalski,
  Independent Vice Chairman of the Supervisory Board
• Anna Bielinska,
  Director of Public Relations and Investor Relations
• Andrzej Bialy,
  Finance Director
• James Robert McMullen,
  Controller
• Michael Paul Derstine,
  Exec. VP & Chief Risk Officer
• Brian Michael Gould,
  EVP & COO
• Rohit Gupta,
  President and CEO
• Brian Gould,
  EVP & Chief Operations Officer
• James Mc Mullen,
  Controller
• Hardin Dean Mitchell,
  EVP, CFO and Treasurer
• Evan Stolove,
  EVP, Gen. Counsel & Secretary
• Michael Derstine,
  EVP and Chief Risk Officer
• Fred G Weiss,
  Director
• Ronald R Taylor,
  Director
• Jack Michelson,
  Director
• Cathy Klema,
  Director
• Andrew L Turner,
  Director
• Albert F Hummel,
  Director
• Michael J Fedida,
  Director
• George Fred Wilkinson,
  Pres-Global Brands&Biosimilars
• Michel J Feldman,
  Director
• R Todd Joyce,
  CFO-Global & PAO
• Sigurdur O Olafsson,
  Pres-Global Generics
• Chris W Bodine,
  Director
• Robert A Stewart,
  Pres-Global Operations
• Albert Iii Paonessa,
  President of Anda, Inc.
• Charles M Mayr,
  Chief Communic Off-Global
• Charles D Ebert,
  Sr. VP, Research & Development
• David A Buchen,
  Chief Legal Officer-Global&Sec
• Hafrun Fridriksdottir,
  Sr VP,Global Generics R&D
• Patrick Eagan,
  Chief HR Officer - Global
• Paul Bisaro,
  President & CEO
• Dominic James Addesso,
  Director
• Robert P Jr Restrepo,
  Director
• John D Fisk,
  Director
• Anne G Waleski,
  Director
• Westley V Thompson,
  Director
• Daniel J Iv Sheehan,
  Director
• Debra Still,
  Director
• Holdings, Inc. Genworth,
  
• Michael A Bless,
  Director
• Raymond T Odierno,
  Director
• Sheila Hooda,
  Director